Last reviewed · How we verify

Bupropion Sustained Release

Iowa City Veterans Affairs Medical Center · Phase 2 active Small molecule

Norepinephrine-dopamine reuptake inhibitor

Norepinephrine-dopamine reuptake inhibitor Used for Major depressive disorder, Seasonal affective disorder.

At a glance

Generic nameBupropion Sustained Release
Also known asZyban, Zyban, Wellbutrin
SponsorIowa City Veterans Affairs Medical Center
Drug classNorepinephrine-dopamine reuptake inhibitor
ModalitySmall molecule
Therapeutic areaNeurology
PhasePhase 2

Mechanism of action

Bupropion works by inhibiting the reuptake of norepinephrine and dopamine in the brain, increasing their levels and activity.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: